Dr. Scott Howard Deckelbaum, DO

Dr. Deckelbaum practices at Concord Hospital in Concord, New Hampshire, part of Concord Hospital Health System.

Dr. Deckelbaum's NPI, 1730100892, was assigned on July 22, 2006. Dr. Deckelbaum graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2003. Dr. Deckelbaum holds New Hampshire license 23933.

Dr. Deckelbaum's primary practice is Concord Hospital, at 250 Pleasant St, Concord, NH 03301 in Merrimack County. The practice phone is (603) 225-2711.

Dr. Deckelbaum's primary practice is Concord Hospital in Concord, New Hampshire, part of Concord Hospital Health System. Dr. Deckelbaum is also affiliated with Concord Hospital - Laconia. The medical group on file is Concord Hospital. Dmand AI also links Dr. Deckelbaum to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deckelbaum practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Deckelbaum's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Deckelbaum is board certified in dermatology by the AOA Board of Dermatology. Dmand AI has Dr. Deckelbaum's licenses on file in 5 states: New Hampshire, California, Florida, New York and Oklahoma.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, rash, scalp rash and skin cyst among the conditions Dr. Deckelbaum treats.

CMS data shows 3,125 Medicare services from Dr. Deckelbaum across 25 procedure codes in 2024, for 585 Medicare patients. Medicare paid $135,074 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 585 Medicare patients who saw Dr. Deckelbaum in 2024. The largest group is 65 to 74, with 268 patients. 63% of them have high cholesterol, and 62% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deckelbaum's median patient age at 70, with 45% women.

In 2024, Dr. Deckelbaum wrote 638 Medicare Part D claims for 358 patients. 94% of them were for generic drugs. CMS names the drug for 527 of them, across 13 drugs with 11 or more claims each, at $88,099 in total drug cost. In 2023, CMS named 106 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Deckelbaum for performance year 2024, reported through an alternative payment model (APM). Dr. Deckelbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 91 procedures of melanoma (skin cancer) excision by Dr. Deckelbaum, more than 92% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Deckelbaum in 2013. 2013 was the busiest year, with 2. Dr. Deckelbaum's most frequent co-authors are Paul K. Shitabata, MD, David J. Sire, MD and Khasha Touloei, DO.

CMS Open Payments shows 68 general payments to Dr. Deckelbaum from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Sanofi and Genzyme US Companies paid the most, $465.

Dr. Deckelbaum graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2003. Dr. Deckelbaum is a member of AAD and AOA.

Dr. Deckelbaum is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.